Article Details

Roche culls two COVID drug hopefuls amid Q1 clear-out

Retrieved on: 2021-04-21 07:30:00

Tags for this article:

Click the tags to see associated articles and topics

Roche culls two COVID drug hopefuls amid Q1 clear-out. View article details on hiswai:

Excerpt

Roche has cut a series of experimental lung drugs from its pipeline, including two midstage COVID assets. The first drug, an Amgen-licensed anti-ST2 ...

Article found on: www.fiercebiotech.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up